ELIZABETH HALLSTROM: Open Payments
NPI 1114233806 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 40 payments from 17 companies in 2025. Trend: 2023 $801 · 2024 $1,474 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $128 |
| GENZYME CORPORATION | 3 | $97 |
| Lilly USA, LLC | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $58 |
| UCB, Inc. | 2 | $40 |
| Incyte Corporation | 2 | $37 |
Products named: DUPIXENT, NEMLUVIO, COSENTYX, TALTZ, Zoryve, SKYRIZI, ILUMYA, Bimzelx.
Industry payments across AZ — which companies pay providers there.
